Epigenetic Aging and Aging Clocks

Epigenetic aging refers to the systematic changes in the epigenome — most prominently in DNA methylation patterns — that accompany chronological ageing. Epigenetic aging clocks turn these changes into a quantitative estimate of biological age, using methylation levels at selected sites to predict age and, in some cases, to flag accelerated ageing relative to the calendar.

Definition

An epigenetic aging clock is a statistical model that estimates biological age from DNA-methylation levels at a defined set of CpG sites; the difference between predicted (epigenetic) age and chronological age — epigenetic age acceleration — is studied as a candidate marker of biological ageing and health risk.

Scope

This entry covers how methylation changes with age, how multi-site clocks are built and interpreted, the distinction between chronological-age predictors and mortality-oriented biomarkers, and the place of epigenetic alteration among the broader hallmarks of ageing. It is a reference treatment of the science and is not a basis for individual health assessment or anti-ageing claims.

Core questions

• How does the methylome change systematically with age?
• How are epigenetic clocks constructed and validated across tissues?
• What does epigenetic age acceleration predict, and how reliably?
• Is epigenetic ageing a cause, consequence, or correlate of ageing?

Key concepts

• DNA methylation age (DNAm age)
• Epigenetic age acceleration
• Multi-tissue versus single-tissue clocks
• First-generation versus mortality-based clocks
• Epigenetic alteration as a hallmark of aging
• CpG site selection by penalized regression

Mechanisms

With age, the methylome undergoes characteristic changes — global hypomethylation alongside focal hypermethylation at specific CpG sites — and these epigenetic alterations are recognized as one of the hallmarks of ageing (López-Otín et al., 2013). Aging clocks exploit this regularity by selecting CpG sites whose methylation tracks chronological age and combining them with penalized regression into an age predictor. The Horvath (2013) multi-tissue clock estimates age across many tissue types from 353 CpGs, while the Hannum et al. (2013) clock was derived in blood; later 'second-generation' clocks were trained on mortality and health outcomes rather than chronological age alone (Horvath & Raj, 2018). The biological drivers linking these marks to the ageing process are still being worked out.

Clinical relevance

Epigenetic clocks are research tools for studying biological ageing and population health, and epigenetic age acceleration has been associated with health outcomes in observational studies. This entry describes the science; it does not endorse epigenetic-age testing for individual diagnosis, prognosis, or anti-ageing intervention.

Epidemiology

Epigenetic clocks have been applied across large cohorts, where epigenetic age acceleration shows associations with mortality, age-related disease, and exposures such as smoking and obesity, though effect sizes and clinical utility vary by clock and population (Horvath & Raj, 2018). Estimates depend on tissue, array platform, and the outcome on which a clock was trained.

History

Age-related methylation changes were observed before clocks existed, but quantitative prediction arrived in 2013 with two landmark models: Hannum and colleagues' blood-based clock and Horvath's multi-tissue clock (Hannum et al., 2013; Horvath, 2013). The framing of epigenetic alteration as a hallmark of ageing (López-Otín et al., 2013) set the conceptual context, and the subsequent 'epigenetic clock theory of ageing' review consolidated the field (Horvath & Raj, 2018).

Debates

Does epigenetic age measure ageing itself or merely correlate with it?

Clocks predict chronological age accurately and age acceleration associates with outcomes, but whether the underlying methylation changes drive ageing, passively record it, or reflect cell-composition shifts remains unresolved and limits causal interpretation.

Key figures

• Steve Horvath
• Gregory Hannum
• Kang Zhang
• Kenneth Raj
• Carlos López-Otín

Seminal works

• hannum-2013
• horvath-2013
• horvath-raj-2018

Frequently asked questions

What is the difference between epigenetic age and chronological age?

Chronological age is time since birth, whereas epigenetic age is an estimate of biological age derived from DNA-methylation patterns; when epigenetic age exceeds chronological age, this is called epigenetic age acceleration and is studied as a possible marker of faster biological ageing.

Can an epigenetic clock tell how long someone will live?

No. Epigenetic clocks describe associations at the population level between age acceleration and outcomes such as mortality risk; they are research tools and do not predict an individual's lifespan or guide personal health decisions.